Takeda Pharmaceutical to Form New Joint Venture With PRA in Japan, Restructure Clinical Development
Takeda Pharmaceutical Co. Ltd. (TYO:4502) recently announced a new clinical development approach in Japan that it will run in partnership……
Please subscribe to read the full story.
Author
